IFI16 and atherosclerosis: Metformin's ability to inhibit cell proliferation and migration of human aortic SMCs is diminished when IFI16 is silenced,152, 153 indicating IFI16's protective role against vascular remodeling and atherosclerosis (Figure 5B).